Q32 Bio (QTTB) Stock Soars 60% After Positive Alopecia Areata Trial Results
Q32 Bio (QTTB) stock rallied 60% after bempikibart achieved its primary endpoint in alopecia areata trial, with registration program planned for 2027. The post Q32 Bio (QTTB) Stock Soars 60% After…
Read the full articleYou might also wanna read
Alcoa Corporation (AA) Stock: Slides Following Strong Q2 Results and $4.1B South32 Acquisition
parameter.io·9h ago
Intuitive Surgical, Inc. (ISRG) Stock: Surges as Q2 Revenue Jumps 19% and Robotic Surgery Growth Shines
parameter.io·9h ago
Broadcom Inc. (AVGO) Stock: Shares Slip 5% as Standard Chartered Expands VMware Cloud Partnership
parameter.io·10h ago
CrowdStrike Holdings, Inc. (CRWD): Stock Faces Pressure as Identity Threat Detection Leadership Expands
parameter.io·10h ago
UnitedHealth Group (UNH) Stock: Profit Growth, AI Investments and Cost Discipline Fuel 2026 Momentum
parameter.io·10h ago
The Eastern Company (EML) Stock: Earnings Report and Webcast Details Released Ahead of August Call
parameter.io·11h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.